Medline Inc. Class A Common Stock (MDLN)
NASDAQ · Healthcare · Medical Instruments & Supplies
Medline Inc. Class A Common Stock is a Healthcare company with a market capitalization of $69.26B and a trailing P/E ratio of 34.1.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $0.33 | $0.29 | +13.8% |
| Q4 2025 | February 25, 2026 | $0.38 | $0.24 | +58.3% |
| Q3 2025 | November 4, 2025 | $0.31 | $0.00 | — |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is Medline Inc. Class A Common Stock's market cap?
As of June 29, 2026, Medline Inc. Class A Common Stock (MDLN) has a market capitalization of $69.26B.
What is Medline Inc. Class A Common Stock's P/E ratio?
Medline Inc. Class A Common Stock trades at a trailing price-to-earnings (P/E) ratio of 34.1. Its forward P/E is 26.3.
Does Medline Inc. Class A Common Stock pay a dividend?
Medline Inc. Class A Common Stock does not currently pay a dividend.
What sector is MDLN in?
Medline Inc. Class A Common Stock is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was Medline Inc. Class A Common Stock's revenue?
In its latest reported fiscal year (ending December 31, 2025), Medline Inc. Class A Common Stock reported revenue of $28.43B and net income of $1.16B.
Ask your own questions about MDLN
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.